Back to Search
Start Over
Opening of Ca2+-activated K+ channels is involved in ischemic preconditioning in canine hearts
- Source :
- Journal of Molecular and Cellular Cardiology.
- Publication Year :
- 2004
- Publisher :
- Elsevier BV, 2004.
-
Abstract
- Brief periods of ischemia that precede sustained ischemia can markedly reduce infarct size (IS), a phenomenon that is known as ischemic preconditioning (IP). Several investigators have shown that elevation of the intracellular Ca(2+) level ([Ca(2+)](i)) during the antecedent brief periods of ischemia triggers the cardioprotective mechanism of IP. Since opening of Ca(2+) activated K(+) (K(Ca)) channels is reported to be cardioprotective, we hypothesized that these channels may be involved in the cardioprotective mechanism of IP. In anesthetized open-chest dogs, myocardial ischemia/reperfusion injury was created by occlusion of the left anterior descending coronary artery (LAD) for 90 min followed by 6 h of reperfusion. First, we showed that the treatment with NS1619, a K(Ca) channel opener, reduced IS (IS in NS1619 group and control group, 19.8 +/- 5.5% vs. 45.4 +/- 3.5% of the area at risk, P < 0.05). Next, four cycles coronary occlusion for 5 min and reperfusion (IP) were performed before the 90-min occlusion with or without the infusion of potent K(Ca) channel inhibitors, iberiotoxin (IbTX) and charybdotoxin (ChTX). IP markedly reduced IS (IS in the IP group was 8.2 +/- 1.8%, P < 0.01 vs. control group). Infusion of either of K(Ca) channel blockers during IP blunted the IS-limiting effect of IP (IS in the IP + IbTX and IP + ChTX groups was 30.7 +/- 7.0% and 35.5 +/- 3.7%, respectively, P < 0.05, vs. IP group). However, the cardioprotective effect of IP was not blunted by the treatment with ChTX when treated only during reperfusion (14.0 +/- 4.1%). Thus, we conclude that the opening of K(Ca) channel is involved in early trigger phase of the molecular mechanism of IP.
- Subjects :
- medicine.medical_specialty
Charybdotoxin
Myocardial Infarction
Ischemia
Pharmacology
Potassium Channels, Calcium-Activated
chemistry.chemical_compound
Dogs
Internal medicine
medicine
Animals
Channel blocker
Molecular Biology
business.industry
Myocardium
Iberiotoxin
medicine.disease
Potassium channel
chemistry
Coronary occlusion
Ischemic Preconditioning, Myocardial
Cardiology
Ischemic preconditioning
Calcium
Cardiology and Cardiovascular Medicine
business
Reperfusion injury
Subjects
Details
- ISSN :
- 00222828
- Database :
- OpenAIRE
- Journal :
- Journal of Molecular and Cellular Cardiology
- Accession number :
- edsair.doi.dedup.....532d54e894723af130f70b13b86420c5
- Full Text :
- https://doi.org/10.1016/j.yjmcc.2004.09.012